BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24509302)

  • 1. US-guided percutaneous liver biopsy in pediatric liver transplant recipients.
    Mandal S; Miraglia R; Maruzzelli L; Liotta R; Tuzzolino F; Spada M; Riva S; Luca A
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):756-61. PubMed ID: 24509302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and risk stratification of percutaneous biopsies of adult-sized renal allografts in infant and older pediatric recipients.
    Vidhun J; Masciandro J; Varich L; Salvatierra O; Sarwal M
    Transplantation; 2003 Aug; 76(3):552-7. PubMed ID: 12923443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients.
    Sundaram SS; Melin-Aldana H; Neighbors K; Alonso EM
    Liver Transpl; 2006 Jan; 12(1):58-64. PubMed ID: 16382471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver allograft pathology in healthy pediatric liver transplant recipients.
    Briem-Richter A; Ganschow R; Sornsakrin M; Brinkert F; Schirmer J; Schaefer H; Grabhorn E
    Pediatr Transplant; 2013 Sep; 17(6):543-9. PubMed ID: 23834615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
    Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose steroids associated with milder histological changes after pediatric liver transplantation.
    Kosola S; Lampela H; Jalanko H; Mäkisalo H; Lohi J; Arola J; Pakarinen MP
    Liver Transpl; 2013 Feb; 19(2):145-54. PubMed ID: 23109058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology.
    Abraham SC; Furth EE
    Transplantation; 1995 Mar; 59(5):740-6. PubMed ID: 7886803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Unresolved Cholestasis Due to Unknown Etiology Leading to Early Allograft Failure Within the First 3 Months of Liver Transplantation.
    Angelico R; Gerlach UA; Gunson BK; Neil D; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MTP
    Transplantation; 2018 Aug; 102(8):1307-1315. PubMed ID: 29470351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition.
    Jenniskens M; Güiza F; Haghedooren R; Verbruggen S; Joosten K; Langouche L; Van den Berghe G
    Pediatr Crit Care Med; 2018 Dec; 19(12):1120-1129. PubMed ID: 30234740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of ultrasound-guided percutaneous liver biopsy in children following liver transplantation.
    Sornsakrin M; Helmke K; Briem-Richter A; Ganschow R
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):635-7. PubMed ID: 20890218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native liver histology after successful portoenterostomy in biliary atresia.
    Lampela H; Kosola S; Heikkilä P; Lohi J; Jalanko H; Pakarinen MP
    J Clin Gastroenterol; 2014 Sep; 48(8):721-8. PubMed ID: 24275708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease.
    Brauner C; Lankisch TO; Fytili P; Jaroszewicz J; Lehner F; Barg-Hock H; Klempnauer J; Jaeckel E; Manns MP; Wedemeyer H; Negm AA
    Transpl Infect Dis; 2014 Dec; 16(6):958-67. PubMed ID: 25393916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver biopsy-related infection in liver transplant recipients: A current matter of concern?
    Sánchez CL; Len O; Gavalda J; Bilbao I; Castells L; Gelabert MA; Allende H; Pahissa A
    Liver Transpl; 2014 May; 20(5):552-6. PubMed ID: 24395813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute nonsuppurative cholangitis (cholangitis lenta) in pediatric liver transplant patients.
    Lin CC; Sundaram SS; Hart J; Whitington PF
    J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):228-33. PubMed ID: 17667720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of operator experience and frequency of procedure performance on complication rate after ultrasound-guided percutaneous liver biopsies.
    Westheim BH; Aagenæs I; Østensen AB; Sanengen T; Almaas R
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):638-43. PubMed ID: 24177785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late allograft fibrosis in pediatric liver transplant recipients: Assessed by histology and transient elastography.
    Chanpong A; Angkathunyakul N; Sornmayura P; Tanpowpong P; Lertudomphonwanit C; Panpikoon T; Treepongkaruna S
    Pediatr Transplant; 2019 Nov; 23(7):e13541. PubMed ID: 31278842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.
    Kerkar N; Morotti RA; Iyer K; Arnon R; Miloh T; Sturdevant M; Suchy F; Florman S; Emre S
    Clin Transplant; 2011; 25(6):E584-91. PubMed ID: 21919961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.